Ritter Pharmaceuticals Looking for Interns

  • May 08 09:05am
  • Written by: Peter Wang
  • Categories:News

Here is a very interesting opportunity for a Scientific Writing and Business Development Internship with Ritter Pharmaceuticals. This could be a great way to get some insight into industry and gain some valuable experience.

Click for more details: Ritter Intern JD – May2019

Build Your Executive Skills: Media Interviews and Stakeholder Communications

  • April 09 08:04pm
  • Written by: Peter Wang
  • Categories:News

After meeting new faces from co-hosts HBA and Biocom LA, work on building your executive skills in media and stakeholder communications at this interactive program. Creating and articulating purpose-driven, compelling messages are critical leadership competencies, no matter if you are communicating with reporters, HCPs, investors, regulators, payers, employees, or patients. Learn how to convey powerful takeaways to every stakeholder.

At the event, communications gurus and a veteran healthcare reporter will share what it takes to prepare for and participate in an effective media interview, including during a crisis. Moderated by Syneos Health PR, we will cover what a reporter wants from an interview, how to develop and deliver key messages, and how to bridge when asked difficult questions. Attendees will then join small group Communications Training Workshops to hone their skills and get advice from our broader group of experts with experience communicating with all stakeholders.

5:00 PM – 6;00 PM    Networking with HBA and Biocom participants
6:00 PM – 6:30 PM    HBA and Biocom remarks and panel introductions
6:30 PM – 7:30 PM    Panel educational forum
7:30 PM – 8:30 PM    Communications training workshops

Registration information
Event is open to: HBA members and nonmembers
Online registration deadline: 25 April 2019
Onsite (walk-in) registration: Is allowed


MedTech Innovator Fellow Program

  • January 24 02:01pm
  • Written by: Peter Wang
  • Categories:News

VITALS: UCLA Anderson Healthcare Conference 2019

  • January 24 02:01pm
  • Written by: Peter Wang
  • Categories:News

ITALS: UCLA Anderson Healthcare Conference 2019

The UCLA Anderson HBA Healthcare Conference is one of the largest university-led healthcare events in Southern California, connecting 300+ business professionals, students and members of academia. Panels and keynotes feature marquee executives, thinkers and practitioners from a diversity of organizations influencing the future of healthcare.

VITALS 2019: Intersections of Healthcare

Healthcare, one of today’s most debated topics, intersects with the technology, finance, public policy, social impact and retail industries. These intersections influence everything from patient experience to pharmaceutical pricing and shape how consumers interact with the healthcare system. This conference will provide education about the changes coming to the healthcare industry as a result of these dynamic connections. We would like to thank our sponsors, Amgen, DaVita, Edwards Lifesciences, PwC, Microvention, and GLG.

Please visit https://www.eventbrite.com/e/vitals-ucla-anderson-healthcare-conference-2019-tickets-53085374785 for more information.

LMI-Sandler Prize for New Entrepreneurs – Spring Meetup Jan. 23rd @5:30-7:30 PM

  • January 17 11:01pm
  • Written by: Peter Wang
  • Categories:News

This meetup is for all UCLA students interested in participating in the 2018-2019 competition for the Lowell Milken Institute-Sandler Prize for New Entrepreneurs.

Attend to pitch your innovative venture idea to other UCLA students or listen to the ideas of others. Following the presentation, the Lowell Milken Institute will host a reception in the Law School’s Lincoln Alcove. This is an opportunity to form teams with students from other schools at UCLA to compete for the $70,000 first prize! Please RSVP.

This event is sponsored by Lowell Milken Institute for Business Law and Policy and UCLA School of Law. It is a private event, open to all UCLA students. For questions about the competition, please email LMISandlerPrize@law.ucla.edu.

BIG congrats to Kite Pharma!

  • August 28 08:08am
  • Written by: Alex Shen
  • Categories:News

The Los Angeles Times writes about Gilead’s acquisition of Kite Pharma.

“Santa Monica biotech company Kite Pharma Inc. is being acquired by industry giant Gilead Sciences Inc. in an $11.9-billion deal that demonstrates the promise of using a person’s own immune system to fight cancer.”

More at http://www.latimes.com/business/la-fi-gilead-kite-purchase-20170828-story.html

UCLA ranks number one in business creation

  • July 07 02:07am
  • Written by: Alex Shen
  • Categories:News

The Los Angeles Times writes about UCLA grabbing the top spot in business creation and highlights Arie Belldegrun, Ross DeVol, Amir Naiberg, and Thomas Lipkin. Read the full story here: http://www.latimes.com/business/la-fi-ucla-startups-20170707-story.html

Flagship Associate Scientist Position

  • June 04 07:06pm
  • Written by: Devon Gaddini
  • Categories:News

Flagship Biosciences is seeking a cancer biologist and or Immuno-Oncologist to join its Science Team in Colorado. Preferably, this individual has a combination of academic and pharmaceutical experience related to the development of cancer therapeutics. As a Flagship team member, you will interact with the internal team and external pharmaceutical and biotechnology clients to develop fit-for-need IHC assay based diagnostic solutions for drug discovery and clinical trials.


Visit the Flagship website for more information. http://flagshipbio.com/careers/

MedTech Innovator 2015

  • April 21 11:04pm
  • Written by: Alex Shen
  • Categories:News

Research Corporation Technologies is excited to announce that the prize pool for MedTech Innovator 2015 is now over $300,000! Companies that have applied in past years or were selected previously as semi-finalists are welcome to apply again. Applications are due April 30 and open now at http://www.medtechinnovator.com/2015

An exciting change in MedTech Innovator 2015 is the addition of a virtual accelerator. As part of their partnership with AdvaMed, the trade association representing 80 percent of medtech firms in the U.S., the accelerator companies will participate in an Innovation Showcase and compete for the audience vote and over $300,000 in prizes at AdvaMed 2015.

They are now looking for 20 outstanding medtech and digital health technologies. If selected, participants will have a unique opportunity to interact with and learn from mentors at key industry stakeholders such as AdvaMed, BD Medical, RCT Ventures, and the Johnson & Johnson Family of Companies. You can read more about this year’s program here. If you are interested in participating as an industry mentor, please contact Paul Grand at Research Corporation Technologies.

Company applications must be submitted by April 30 at http://www.medtechinnovator.com/2015

Early applications are encouraged, as it gives our judges more time to consider the applications. Please pass this along to others involved in medtech innovation and transformation. You can follow us on Twitter at @MedTechAwards for news and updates on this year’s competition.

Job Opening for Advanced Concepts Scientist

  • April 14 06:04pm
  • Written by: Devon Gaddini
  • Categories:News

Advanced Concepts team will be hiring 2 scientists starting July 1st, 2015.  They are looking for PhDs from any scientific background (polymer chemistry is a plus).  PhDs must have a good blend of science and business understanding, and the job is located in Minnesota. Please email Samantha at SamanthaLe@mednet[dot]ucla[dot]com if you’re interested.

The Advanced Concepts Team (ACT) will be developing and evaluating technologies that are 5+ years out from product feasibility starting July 1st.  ACT will solely be focused on transformational technologies that can have a major impact in the cardiovascular space.   ACT projects will:

  1. Solve large unmet medical needs in the cardiovascular space
  2. Have a radical technological solution that is understood enough such that  concept feasibility is viable

ACT will focus on ‘connecting dots differently’ by pulling from different fields and rethinking current treatment paradigms.  ACT will drive concepts through determination of feasibility.  To do this, ACT will leverage the skillsets of the diverse team, connections with academia, and contractors to develop proof of concepts for these new devices and technologies.


•Identify unmet medical needs in the cardiovascular spaceThis will be done through observation, conference attendance, literature review, and customer interactions.

•Validate need by working with the market expansion team, sales, marketing, and gathering KOL feedback

•Identify new and emerging technologies that have the potential to be used in the cardiovascular space

•This will include monitoring university IP, scientific articles, attending conferences, and identifying early stage startups

•Provide foundational research on emerging technologies to the larger organization

•Ideate on how to apply emerging technologies to address an unmet medical need

•Develop, lead, and drive the execution of proof of concept plans for solutions to an unmet medical need

•Proof of concept can include benchtop and preclinical studies

•Utilize resources within the company as well as external resources

•Participate in the creation of value propositions and business rationale for promising concepts.

•Work cooperatively with market expansion team, corporate development, regulatory, clinical, engineering, marketing, and other key stakeholders

•Strengthen ties and relationships with academics and thought leaders

•Help to develop sponsored research programs

•Evaluate and recognize market changes and threats within the cardiovascular space

•Travel approximately 15% of the time for conferences, research, etc.